PROGNOMIQ
PrognomiQ is a technology company that focuses on transforming early disease detection and treatment through multi-omics data. The company generates extensive proteomic, genomic, and metabolomic data to provide insights into complex diseases, aiming to improve patient outcomes. PrognomiQ's innovative approach facilitates the development of advanced test products that enhance the understanding and management of health conditions.
PROGNOMIQ
Industry:
Biopharma Biotechnology Health Care Medical Device
Founded:
2020-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.prognomiq.com
Total Employee:
11+
Status:
Active
Contact:
650 750-2447
Email Addresses:
[email protected]
Total Funding:
135 M USD
Technology used in webpage:
HSTS Google Maps Amazon CrUX Dataset CrUX Top 50m Amazon Virginia Region Ruby On Rails Token Envoy Amazon Oregon Region Pexels
Similar Organizations
Laparo
The team of software and hardware engineers who are pushing the boundaries of laparoscopy training and education.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Investors List
Invus
Invus investment in Series D - PrognomiQ
aMoon Fund
aMoon Fund investment in Series D - PrognomiQ
Catalio Capital Management
Catalio Capital Management investment in Series D - PrognomiQ
Seer
Seer investment in Series D - PrognomiQ
Bruker
Bruker investment in Series D - PrognomiQ
Emerson Collective
Emerson Collective investment in Venture Round - PrognomiQ
Fidelity
Fidelity investment in Venture Round - PrognomiQ
Maverick Ventures
Maverick Ventures investment in Venture Round - PrognomiQ
aMoon Fund
aMoon Fund investment in Venture Round - PrognomiQ
Bruker
Bruker investment in Venture Round - PrognomiQ
Official Site Inspections
http://www.prognomiq.com Semrush global rank: 7 M Semrush visits lastest month: 995
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PrognomiQ"
PrognomiQ - Crunchbase Company Profile & Funding
PrognomiQ is a technology company that focuses on transforming early disease detection and treatment through multi-omics data. The company generates …See details»
PrognomiQ Inc - LinkedIn
PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver ...See details»
FACT SHEET - prognomiQ
About PrognomiQ . PrognomiQ. is a healthcare company focused on harnessing the power of multi-omics data to transform the detection and early treatment selection and monitoring of …See details»
PrognomIQ 2025 Company Profile: Valuation, Funding …
PrognomIQ General Information Description. Developer of medical test products designed to transform the detection and treatment of cancer and other …See details»
PROGNOMIQ INC Company Profile | San Mateo, CA - Dun
Find company research, competitor information, contact details & financial data for PROGNOMIQ INC of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
PrognomiQ - Funding, Financials, Valuation & Investors
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data. New. Resources. ... How much funding has this …See details»
PrognomiQ - The Org
PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver first-in-class test products that enable early …See details»
Fact Sheet | Download Now - prognomiQ
1900 Alameda de las Pulgas, Suite 100 San Mateo, CA 94403 [email protected] Media Inquiries [email protected] Client Services Phone: (650) 750-2447 Fax: (650) 750-2460See details»
PrognomiQ Company Profile - Office Locations, Competitors
PrognomiQ is a company that develops test products that enable early disease detection and treatment. It generates proprietary proteomic data at unparalleled volumes and depth of …See details»
PrognomiQ - VentureRadar
PrognomiQ is developing transformative test products that enable early disease detection and treatment. We do this by generating proprietary proteomic data at unparalleled volumes and …See details»
PrognomiQ - Contacts, Employees, Board Members, Advisors
PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data. ... Experience the new Crunchbase, powered by AI . …See details»
PrognomiQ - Bioinformatics Team - The Org
The Bioinformatics Team at PrognomiQ is responsible for analyzing and interpreting complex proteomic and multi-omic data to enhance the understanding of disease mechanisms. They …See details»
PrognomiQ Inc Company Overview, Contact Details
Nov 5, 2024 PrognomiQ Inc. Biotechnology Research California, United States 51-200 Employees. PrognomiQ aims to generate proteomic information with high accuracy, scale and …See details»
Careers - prognomiQ
At PrognomiQ, we aim to transform healthcare by generating and using systems biology data to develop and commercialize tests for early detection and treatment of cancer and other …See details»
Who Owns PrognomiQ – CANVAS, SWOT, PESTEL & BCG Matrix …
Oct 2, 2024 In 2019, PrognomiQ announced a strategic partnership with Pharma Innovations, a global pharmaceutical giant, to co-develop and commercialize a range of diagnostic tests …See details»
PrognomIQ Career Opportunities
At PrognomiQ, we aim to transform healthcare by generating and using systems biology data to develop and commercialize tests for early detection and treatment of cancer and other …See details»
NEWS & RESOURCES - prognomiQ
Nov 29, 2022 PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform. Read More. 01/08/2024. …See details»
3iQ Becomes Canada's Largest Solana ETF Following Launch
22 hours ago Superior Institutional Partnerships & World-Class Staking Providers Push 3iQ Solana Staking ETF (TSX: SOLQ, SOLQ.U) to Become Canada's Largest by AUM. …See details»
PrognomiQ Announces $34 Million Series D Financing to Advance ...
San Mateo, Calif. – November 5, 2024 – PrognomiQ – a healthcare company focused on harnessing the power of multi-omics data to transform the detection and early treatment …See details»
$46 Million Financing to Advance Multi-omics Product Pipeline
Jan 8, 2025 PrognomiQ Announces $46 Million Financing to Advance Development of its Multi-omics Product Pipeline for Early Detection and Treatment of Cancer PrognomiQ – a …See details»